Berlin, Germany

Jorma Hassfeld

USPTO Granted Patents = 5 

 

 

Average Co-Inventor Count = 5.3

ph-index = 1

Forward Citations = 8(Granted Patents)


Location History:

  • Nienburg, DE (2006)
  • Berlin, DE (2013 - 2018)
  • Düsseldorf, DE (2022)

Company Filing History:


Years Active: 2006-2022

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovations of Jorma Hassfeld

Introduction

Jorma Hassfeld, an accomplished inventor based in Berlin, Germany, is recognized for his contributions to the field of pharmaceuticals. With a robust portfolio of five patents, his work focuses primarily on the development of novel compounds and methods that address various medical needs.

Latest Patents

Hassfeld's latest innovations include methods for the preparation of 2,4,5-trisubstituted 1,2,4-triazolone. This invention outlines the processes for synthesizing a specific compound, along with the use of intermediates for the preparation of this compound and its crystalline form. Furthermore, he has developed 5-[(3,3,3-trifluoro-2-hydroxy-1-arylpropyl)amino]-1H-quinolin-2-ones, which details a production process for these compounds and highlights their potential as anti-inflammatory agents.

Career Highlights

Throughout his career, Jorma Hassfeld has collaborated with renowned companies such as Bayer Aktiengesellschaft and Bayer Pharma Aktiengesellschaft. His tenure at these companies showcases his commitment to driving innovation in pharmaceutical sciences.

Collaborations

In the course of his professional journey, Hassfeld has worked alongside notable coworkers, including Markus Berger and Hartmut Rehwinkel. These collaborations have undoubtedly contributed to his success and the development of impactful inventions.

Conclusion

Jorma Hassfeld's inventive spirit and dedication to creating impactful solutions in the pharmaceutical industry reflect his significant role as an inventor. His contributions through patents continue to enhance our understanding and treatment of various medical conditions, underscoring the vital interplay between innovation and healthcare advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…